Which has higher earnings & valuation, APLMW or ALVOW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Apollomics $8.50M N/A N/A N/A N/A Alvotech $491.95M N/A N/A N/A N/A

Is APLMW or ALVOW more profitable?

Company Net Margins Return on Equity Return on Assets Apollomics N/A N/A N/A Alvotech N/A N/A N/A

Which has stronger earnings and valuation, ARAV or ALVOW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aravive N/A N/A N/A -$0.90 N/A Alvotech $491.95M N/A N/A N/A N/A

Is ARAV or ALVOW more profitable?

Company Net Margins Return on Equity Return on Assets Aravive N/A N/A N/A Alvotech N/A N/A N/A

Which has stronger valuation and earnings, ALVOW or BIAFW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alvotech $491.95M N/A N/A N/A N/A bioAffinity Technologies $5.85M N/A N/A N/A N/A

Is ALVOW or BIAFW more profitable?

Company Net Margins Return on Equity Return on Assets Alvotech N/A N/A N/A bioAffinity Technologies N/A N/A N/A

Which has stronger earnings & valuation, BIVIW or ALVOW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio BioVie N/A N/A N/A N/A N/A Alvotech $491.95M N/A N/A N/A N/A

Is BIVIW or ALVOW more profitable?

Company Net Margins Return on Equity Return on Assets BioVie N/A N/A N/A Alvotech N/A N/A N/A

Which has stronger earnings and valuation, CDIOW or ALVOW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cardio Diagnostics $14.45K N/A N/A N/A N/A Alvotech $491.95M N/A N/A N/A N/A

Is CDIOW or ALVOW more profitable?

Company Net Margins Return on Equity Return on Assets Cardio Diagnostics N/A N/A N/A Alvotech N/A N/A N/A

Alvotech (ALVOW) Competitors

$0.30 0.00 (0.00%)

As of 09/11/2026

Compare

ALVOW vs. APLMW, ARAV, BIAFW, BIVIW, and CDIOW

Should you buy Alvotech stock or one of its competitors? Alvotech's main competitors and comparable companies include Apollomics (APLMW), Aravive (ARAV), bioAffinity Technologies (BIAFW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Alvotech compare to Apollomics?

Apollomics (NASDAQ:APLMW) and Alvotech (NASDAQ:ALVOW) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, earnings, analyst recommendations, valuation and institutional ownership.

In the previous week, Apollomics and Apollomics both had 1 articles in the media. Apollomics' average media sentiment score of 1.89 beat Alvotech's score of 1.87 indicating that Apollomics is being referred to more favorably in the media.

Company	Overall Sentiment
Apollomics	Very Positive
Alvotech	Very Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apollomics	$8.50M	N/A	N/A	N/A	N/A
Alvotech	$491.95M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Apollomics	N/A	N/A	N/A
Alvotech	N/A	N/A	N/A

Summary

Apollomics and Alvotech tied by winning 1 of the 2 factors compared between the two stocks.

How does Alvotech compare to Aravive?

Aravive (NASDAQ:ARAV) and Alvotech (NASDAQ:ALVOW) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

In the previous week, Alvotech had 1 more articles in the media than Aravive. MarketBeat recorded 1 mentions for Alvotech and 0 mentions for Aravive. Alvotech's average media sentiment score of 1.87 beat Aravive's score of 0.00 indicating that Alvotech is being referred to more favorably in the news media.

Company	Overall Sentiment
Aravive	Neutral
Alvotech	Very Positive

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aravive	N/A	N/A	N/A	-$0.90	N/A
Alvotech	$491.95M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Aravive	N/A	N/A	N/A
Alvotech	N/A	N/A	N/A

Summary

Alvotech beats Aravive on 3 of the 5 factors compared between the two stocks.

How does Alvotech compare to bioAffinity Technologies?

Alvotech (NASDAQ:ALVOW) and bioAffinity Technologies (NASDAQ:BIAFW) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, risk, institutional ownership, earnings, dividends and analyst recommendations.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alvotech	$491.95M	N/A	N/A	N/A	N/A
bioAffinity Technologies	$5.85M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Alvotech	N/A	N/A	N/A
bioAffinity Technologies	N/A	N/A	N/A

In the previous week, Alvotech and Alvotech both had 1 articles in the media. bioAffinity Technologies' average media sentiment score of 1.89 beat Alvotech's score of 1.87 indicating that bioAffinity Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Alvotech	Very Positive
bioAffinity Technologies	Very Positive

Summary

Alvotech and bioAffinity Technologies tied by winning 1 of the 2 factors compared between the two stocks.

How does Alvotech compare to BioVie?

BioVie (NASDAQ:BIVIW) and Alvotech (NASDAQ:ALVOW) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk, media sentiment and valuation.

Company	Net Margins	Return on Equity	Return on Assets
BioVie	N/A	N/A	N/A
Alvotech	N/A	N/A	N/A

In the previous week, BioVie had 1 more articles in the media than Alvotech. MarketBeat recorded 2 mentions for BioVie and 1 mentions for Alvotech. Alvotech's average media sentiment score of 1.87 beat BioVie's score of 0.94 indicating that Alvotech is being referred to more favorably in the news media.

Company	Overall Sentiment
BioVie	Positive
Alvotech	Very Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioVie	N/A	N/A	N/A	N/A	N/A
Alvotech	$491.95M	N/A	N/A	N/A	N/A

Summary

Alvotech beats BioVie on 2 of the 3 factors compared between the two stocks.

How does Alvotech compare to Cardio Diagnostics?

Cardio Diagnostics (NASDAQ:CDIOW) and Alvotech (NASDAQ:ALVOW) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, analyst recommendations, dividends, media sentiment, institutional ownership and profitability.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardio Diagnostics	$14.45K	N/A	N/A	N/A	N/A
Alvotech	$491.95M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Cardio Diagnostics	N/A	N/A	N/A
Alvotech	N/A	N/A	N/A

In the previous week, Cardio Diagnostics and Cardio Diagnostics both had 1 articles in the media. Cardio Diagnostics' average media sentiment score of 1.89 beat Alvotech's score of 1.87 indicating that Cardio Diagnostics is being referred to more favorably in the media.

Company	Overall Sentiment
Cardio Diagnostics	Very Positive
Alvotech	Very Positive

Summary

Cardio Diagnostics and Alvotech tied by winning 1 of the 2 factors compared between the two stocks.

Get Alvotech News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALVOW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ALVOW vs. The Competition

Export

Metric	Alvotech	Biotechnology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$3.85B	$7.15B	$12.85B
Dividend Yield	N/A	3.65%	2.57%	11.17%
P/E Ratio	N/A	14.18	274.94	25.36
Price / Sales	N/A	1,374.99	686.57	116.78
Price / Cash	N/A	106.50	76.65	51.52
Price / Book	N/A	15.12	10.33	6.20
Net Income	N/A	-$22.86M	$3.50B	$358.50M
7 Day Performance	-1.50%	-4.34%	-3.32%	-2.35%
1 Month Performance	55.44%	0.54%	-0.53%	-3.23%
1 Year Performance	-69.22%	40.74%	23.51%	8.79%

Alvotech Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ALVOW Alvotech	N/A	$0.30 flat	N/A	N/A	$0.00	$491.95M	N/A	4	Gap Down
APLMW Apollomics	N/A	$0.01 flat	N/A	-21.1%	$0.00	$8.50M	N/A	59
ARAV Aravive	N/A	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	20	High Trading Volume
BIAFW bioAffinity Technologies	N/A	$0.70 +79.0%	N/A	+237.2%	$0.00	$5.85M	N/A	10	Gap Down High Trading Volume
BIVIW BioVie	N/A	$0.36 -0.6%	N/A	N/A	$0.00	N/A	N/A	N/A	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ALVOW) was last updated on 9/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alvotech (ALVOW) Competitors